Manufacturing of Next-Generation Cellular Immunotherapies using a Novel Induced Pluripotent Stem Cell Platform

Time: 11:45 am
day: Day One

Details:

  • Outline advantage of iPSC derived platform
  • Discuss some challenges
  • Review potential scale up opportunities

Speakers: